BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15129416)

  • 1. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.
    Commissaris RL; Fomum EA; Leavell BJ
    Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of hypocretins on noise-alone versus potentiated startle responses.
    Singareddy R; Uhde T; Commissaris R
    Physiol Behav; 2006 Dec; 89(5):650-5. PubMed ID: 17028045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone.
    Winslow JT; Noble PL; Davis M
    Biol Psychiatry; 2007 Feb; 61(3):389-95. PubMed ID: 16730332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia.
    McQueen DA; Overstreet DH; Ardayfio PA; Commissaris RL
    Behav Pharmacol; 2001 Nov; 12(6-7):509-16. PubMed ID: 11742145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.
    Walker DL; Davis M
    Biol Psychiatry; 1997 Sep; 42(6):461-71. PubMed ID: 9285082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man.
    Scaife JC; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2005 Jul; 19(4):347-56. PubMed ID: 15982989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-enhanced startle: further pharmacological and behavioral characterization.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Jan; 159(3):304-10. PubMed ID: 11862363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonextinction procedure for long-term studies of classically conditioned enhancement of acoustic startle in the rat.
    Winston CR; Leavell BJ; Ardayfio PA; Beard C; Commissaris RL
    Physiol Behav; 2001 May; 73(1-2):9-17. PubMed ID: 11399289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.
    Thompson BL; Rosen JB
    Neuropeptides; 2000 Feb; 34(1):38-44. PubMed ID: 10688967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
    J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic treatments do not increase fear-potentiated startle in mice.
    Risbrough VB; Geyer MA
    Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
    Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
    Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD.
    Matar MA; Zohar J; Kaplan Z; Cohen H
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):283-95. PubMed ID: 19167197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle.
    Santos JM; Gárgaro AC; Oliveira AR; Masson S; Brandão ML
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):239-46. PubMed ID: 15695072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the acoustic startle response by a conditioned stimulus paired with acoustic startle stimulus in rats.
    Leaton RN; Cranney J
    J Exp Psychol Anim Behav Process; 1990 Jul; 16(3):279-87. PubMed ID: 2398339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.